Sneha Rangarajan

Sneha R. currently serves as Director at Kemp Proteins, focusing on expression, cell culture, and fermentation since May 2023. Prior to this role, Sneha held positions at IDT Biologika from January 2019 to May 2023, progressing from Senior Scientist and Team Lead specializing in gene therapy and viral vectors to Scientist II and Project Lead on gene therapy and vaccine development projects. Sneha's experience also includes working as a Scientist at CPL Biologicals US. LLC from December 2017 to January 2019, developing seasonal influenza vaccine candidates, and completing a postdoctoral fellowship at the IBBR Institute for Bioscience and Biotechnology Research from August 2012 to November 2017, where research involved therapeutic targets for Hepatitis C Virus vaccine development. Sneha earned a PhD in Biomedical Sciences from the University at Albany School of Public Health and a Master of Science in Biochemistry from the University of Mumbai.